SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCI...( Recent Accompli...)

Recent Accomplishments Include: - Receipt of GRAS (Generally Recognized As Safe) designation for Sucralose Enhancer S2383, which allows commercialization in the U.S. and elsewhere

- New collaboration with Firmenich SA for commercialization of S2383 - Initiation of safety studies to support regulatory filings for Sucrose

(table sugar) Enhancer S6973 - Achievement of a milestone in collaboration with Solae to develop bitter

blockers that improve the taste of hydrolyzed soy protein - Achievement of a milestone in collaboration with The Coca-Cola Company

related to Senomyx's discovery of a promising new flavor ingredient

SAN DIEGO, CA, Nov. 6, 2008 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX), a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today reported financial results for the second quarter ended September 30, 2008. Revenues were $13.7 million for the nine months ended September 30, 2008, compared to $11.9 million for the nine months ended September 30, 2007, an increase of 15%. As of September 30, 2008, the Company had cash, cash equivalents, and short term investments of approximately $43.2 million.

"Senomyx had outstanding accomplishments during the past few months," said Kent Snyder, President and Chief Executive Officer of the Company. "The recent GRAS (Generally Recognized As Safe) designation for our sucralose enhancer, S2383, was a milestone that validates Senomyx's discovery, development, and regulatory expertise. Within 18 months of its discovery, S2383 has achieved regulatory status that allows commercialization
'/>"/>